| Product Code: ETC8836852 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Cancer Care market in the Philippines encompasses a wide range of services and products, from diagnostics and surgery to chemotherapy, radiotherapy, and palliative care. With cancer incidence rising, investments in oncology centers, treatment infrastructure, and trained professionals are growing to meet patient needs across the country.
The cancer care market in the Philippines is growing due to the rising incidence of cancer and the increasing availability of treatment options. With improvements in healthcare facilities and the introduction of advanced therapies, the market is experiencing expansion in both the public and private sectors. Cancer care includes surgery, chemotherapy, radiotherapy, and supportive services, and its demand will continue to rise as more Filipinos seek comprehensive treatment options.
The cancer care market faces systemic challenges, including insufficient oncology infrastructure, a shortage of specialized healthcare professionals, and unequal access to care across regions. Treatment costs are often beyond the reach of many patients, and public healthcare systems are underfunded and overstretched. Moreover, stigma and lack of awareness continue to hinder early detection and intervention efforts.
As the incidence of cancer continues to rise, the Philippines cancer care market offers ample investment opportunities across various segments, including diagnostics, treatment, and supportive care. The market is growing as more people seek advanced cancer treatments, such as immunotherapy, targeted therapies, and personalized medicine. Additionally, there is a rising demand for cancer care facilities, homecare services, and patient support programs. Investors can explore opportunities in healthcare infrastructure, drug development, and patient care services, especially in underserved regions.
Government healthcare policies that focus on improving cancer care infrastructure contribute to the growth of the cancer care market in the Philippines. The National Cancer Control Program (NCCP) guides initiatives aimed at providing better access to cancer treatments and support services. These policies, combined with international collaborations, facilitate the availability of advanced cancer care options in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Cancer Care Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Cancer Care Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Cancer Care Market - Industry Life Cycle |
3.4 Philippines Cancer Care Market - Porter's Five Forces |
3.5 Philippines Cancer Care Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Philippines Cancer Care Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Philippines Cancer Care Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Philippines Cancer Care Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
4 Philippines Cancer Care Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in the Philippines |
4.2.2 Growing awareness of the importance of early detection and treatment |
4.2.3 Advances in technology and treatments in the cancer care sector |
4.3 Market Restraints |
4.3.1 High cost of cancer treatments and care |
4.3.2 Limited access to quality cancer care services in rural areas |
4.3.3 Lack of skilled healthcare professionals specializing in cancer care |
5 Philippines Cancer Care Market Trends |
6 Philippines Cancer Care Market, By Types |
6.1 Philippines Cancer Care Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Cancer Care Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Philippines Cancer Care Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Philippines Cancer Care Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Philippines Cancer Care Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.6 Philippines Cancer Care Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.1.7 Philippines Cancer Care Market Revenues & Volume, By Other Treatment Types, 2021- 2031F |
6.2 Philippines Cancer Care Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Cancer Care Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.3 Philippines Cancer Care Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.4 Philippines Cancer Care Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 Philippines Cancer Care Market Revenues & Volume, By Gastrointestinal Cancer, 2021- 2031F |
6.2.6 Philippines Cancer Care Market Revenues & Volume, By Gynecologic Cancer, 2021- 2031F |
6.2.7 Philippines Cancer Care Market Revenues & Volume, By Respiratory/Lung Cancer, 2021- 2031F |
6.3 Philippines Cancer Care Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Philippines Cancer Care Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Philippines Cancer Care Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Philippines Cancer Care Market Revenues & Volume, By Cancer and Radiation Therapy Centers, 2021- 2031F |
6.4 Philippines Cancer Care Market, By Therapeutic Class |
6.4.1 Overview and Analysis |
6.4.2 Philippines Cancer Care Market Revenues & Volume, By G-CSFs, 2021- 2031F |
6.4.3 Philippines Cancer Care Market Revenues & Volume, By Bisphosphonates, 2021- 2031F |
6.4.4 Philippines Cancer Care Market Revenues & Volume, By Antiemetic, 2021- 2031F |
6.4.5 Philippines Cancer Care Market Revenues & Volume, By Opioids, 2021- 2031F |
6.4.6 Philippines Cancer Care Market Revenues & Volume, By NSAIDs, 2021- 2031F |
6.4.7 Philippines Cancer Care Market Revenues & Volume, By ESAs, 2021- 2031F |
7 Philippines Cancer Care Market Import-Export Trade Statistics |
7.1 Philippines Cancer Care Market Export to Major Countries |
7.2 Philippines Cancer Care Market Imports from Major Countries |
8 Philippines Cancer Care Market Key Performance Indicators |
8.1 Average survival rates for different types of cancer in the Philippines |
8.2 Adoption rates of new technologies and treatments in cancer care |
8.3 Number of cancer care facilities and specialists in the country |
8.4 Patient satisfaction and outcomes in cancer care services |
8.5 Investment in research and development for cancer treatments and care |
9 Philippines Cancer Care Market - Opportunity Assessment |
9.1 Philippines Cancer Care Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Philippines Cancer Care Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Philippines Cancer Care Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Philippines Cancer Care Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
10 Philippines Cancer Care Market - Competitive Landscape |
10.1 Philippines Cancer Care Market Revenue Share, By Companies, 2024 |
10.2 Philippines Cancer Care Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here